EUR 1.51
(0.67%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 79.48 Million EUR | -11.54% |
2022 | 89.84 Million EUR | 0.82% |
2021 | 89.11 Million EUR | 11.35% |
2020 | 80.03 Million EUR | -12.0% |
2019 | 90.94 Million EUR | -14.88% |
2018 | 106.84 Million EUR | 9.34% |
2017 | 97.71 Million EUR | -1.78% |
2016 | 99.48 Million EUR | 3.62% |
2015 | 96.01 Million EUR | 26.58% |
2014 | 75.84 Million EUR | -2.61% |
2013 | 77.87 Million EUR | -0.88% |
2012 | 78.57 Million EUR | -6.7% |
2011 | 84.21 Million EUR | 0.95% |
2010 | 83.42 Million EUR | 3.53% |
2009 | 80.58 Million EUR | -35.64% |
2008 | 125.2 Million EUR | 25.05% |
2007 | 100.12 Million EUR | 9.08% |
2006 | 91.79 Million EUR | 41.19% |
2005 | 65.01 Million EUR | 11.68% |
2004 | 58.21 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q2 | 81.86 Million EUR | 0.0% |
2023 Q4 | 79.48 Million EUR | 0.0% |
2023 FY | 79.48 Million EUR | -11.54% |
2022 Q4 | 89.84 Million EUR | 0.0% |
2022 Q2 | 105.47 Million EUR | 0.0% |
2022 FY | 89.84 Million EUR | 0.82% |
2021 Q4 | 89.11 Million EUR | 0.0% |
2021 Q2 | 77.62 Million EUR | 0.0% |
2021 FY | 89.11 Million EUR | 11.35% |
2020 Q2 | 86.49 Million EUR | 0.0% |
2020 FY | 80.03 Million EUR | -12.0% |
2020 Q4 | 80.03 Million EUR | 0.0% |
2019 Q4 | 90.94 Million EUR | 0.0% |
2019 Q2 | 91.9 Million EUR | 0.0% |
2019 FY | 90.94 Million EUR | -14.88% |
2018 Q4 | 106.84 Million EUR | 0.0% |
2018 FY | 106.84 Million EUR | 9.34% |
2018 Q2 | 97.7 Million EUR | 0.0% |
2017 FY | 97.71 Million EUR | -1.78% |
2017 Q2 | 94.57 Million EUR | 0.0% |
2017 Q4 | 97.71 Million EUR | 0.0% |
2016 FY | 99.48 Million EUR | 3.62% |
2016 Q2 | 90.8 Million EUR | 0.0% |
2016 Q4 | 99.48 Million EUR | 0.0% |
2015 Q4 | 96.01 Million EUR | 0.0% |
2015 Q2 | 86.42 Million EUR | 0.0% |
2015 FY | 96.01 Million EUR | 26.58% |
2014 Q2 | 79.5 Million EUR | 0.0% |
2014 FY | 75.84 Million EUR | -2.61% |
2014 Q4 | 75.84 Million EUR | 0.0% |
2013 Q4 | 77.87 Million EUR | 0.0% |
2013 Q2 | 86.6 Million EUR | 0.0% |
2013 FY | 77.87 Million EUR | -0.88% |
2012 Q2 | 84.74 Million EUR | 0.0% |
2012 Q4 | 78.57 Million EUR | 0.0% |
2012 FY | 78.57 Million EUR | -6.7% |
2011 Q2 | 86.65 Million EUR | 0.0% |
2011 Q4 | 84.21 Million EUR | 0.0% |
2011 FY | 84.21 Million EUR | 0.95% |
2010 Q2 | 85.33 Million EUR | 0.0% |
2010 FY | 83.42 Million EUR | 3.53% |
2010 Q4 | 83.42 Million EUR | 0.0% |
2009 Q4 | 80.58 Million EUR | 0.0% |
2009 FY | 80.58 Million EUR | -35.64% |
2008 FY | 125.2 Million EUR | 25.05% |
2007 FY | 100.12 Million EUR | 9.08% |
2006 FY | 91.79 Million EUR | 41.19% |
2005 FY | 65.01 Million EUR | 11.68% |
2004 FY | 58.21 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Miliboo Société anonyme | 11.92 Million EUR | -566.275% |
Neolife SA | 3.04 Million EUR | -2510.476% |
Belysse Group NV | 249.83 Million EUR | 68.187% |
Roche Bobois S.A. | 346.17 Million EUR | 77.04% |
SEB SA | 5.79 Billion EUR | 98.628% |
Vista Alegre Atlantis, SGPS, S.A. | 160.41 Million EUR | 50.454% |